Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study

Background: There are no primary prevention trials of aspirin with relevant geriatric outcomes in elderly people. ASPirin in Reducing Events in the Elderly (ASPREE) is a placebo-controlled trial of low-dose aspirin that will determine whether 5 years of daily 100-mg enteric-coated aspirin extends di...

Full description

Bibliographic Details
Main Authors: McNeil, J., Woods, R., Nelson, M., Murray, A., Reid, Christopher, Kirpach, B., Storey, E., Shah, R., Wolfe, R., Tonkin, A., Newman, A., Williamson, J., Lockery, J., Margolis, K., Ernst, M., Abhayaratna, W., Stocks, N., Fitzgerald, S., Trevaks, R., Orchard, S., Beilin, L., Donnan, G., Gibbs, P., Johnston, C., Grimm, R., ASPREE Investigator Group
Format: Journal Article
Published: 2017
Online Access:http://hdl.handle.net/20.500.11937/56779